Results 131 to 140 of about 83,082 (294)
T-Cadherin in Biliary Tract Cancer Stroma, a Potent Pharmacological Target for Biliary Tract Carcinogenesis. [PDF]
Hanamatsu Y, Saigo C, Takeuchi T.
europepmc +1 more source
Operative Endoscopy of the Biliary Tract
Judith Shore, Harvey N. Lippman
openalex +2 more sources
ABSTRACT Background The prevalence of high body mass index (BMI) contributes to an increased risk of various diseases. This study aimed to identify global disease burden trends associated with high BMI from 1990 to 2019 and forecasts up to 2040. Methods Using data from the global burden of disease (GBD) 2019 study, we analysed the number and ratio of ...
Eun‐Ji Kim+4 more
wiley +1 more source
Clinical significance of HER2 overexpression in biliary tract carcinoma --a meta analysis. [PDF]
Xu H, Liang Y, Tang W, Yang X, Du X.
europepmc +1 more source
Bacteriologic Studies Of Biliary Tract Infection
Robert J. Flemma+3 more
openalex +2 more sources
Therapeutic targeting of chromatin alterations in leukemia and solid tumors
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner+7 more
wiley +1 more source
CAQ Corner: Immune‐mediated complications
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley +1 more source
Oral microbiota and biliary tract cancers: unveiling hidden mechanistic links. [PDF]
Zhang Y, Zhang S.
europepmc +1 more source
Anomalies in the extrahepatic biliary tract of the rabbit [PDF]
S. P. Lee
openalex +1 more source
What's New? Exposures and mechanisms that contribute to and promote pancreatic ductal adenocarcinoma (PDAC) remain unclear. In this study, the authors applied metabolomics to better understand PDAC etiology by examining associations between prediagnostic serum metabolites and PDAC risk.
Ting Zhang+7 more
wiley +1 more source